Table 2. Distribution of patients according to MRD status at day 15, day 33 and week 12.
| Time point | MRD monitoring method | Patients N | MRD status |
|
|---|---|---|---|---|
| Positive: >=10−4 N (%) | Negative: <10−4 N (%) | |||
| Day 15 | FC | 135 | 114 (84.4) | 21 (15.6) |
| FC/RQ | 154 | 131 (85.1) | 23 (14.9) | |
| Day 33 | FC | 128 | 28 (21.9) | 100 (78.1) |
| FC/RQ | 150 | 43 (28.7) | 107 (71.3) | |
| Week 12 | FC | 117 | 5 (4.3) | 112 (95.7) |
| FC/RQ | 135 | 7 (5.2) | 128 (94.8) | |
N, the number of patients with available MRD data obtained by flow cytometry (FC) and FC or real-time quantitative PCR (FC/RQ).